Clinical features and management of vestibulitis

I'll start by reading the medical library skill, then search for vestibulitis content in parallel.

Reading File

Now I'll run parallel searches across the library, PubMed, and web simultaneously.

Finding Sources

Searching PubMed

vestibulitis vulvar vestibule treatment

I can see vestibulitis appears in several contexts - nasal vestibulitis (ENT) and vulvar vestibulitis. The question likely asks about nasal vestibulitis (common clinical topic) but may also include vulvar. Let me read the key sections in parallel.

Reading File

The query is clearly about nasal vestibulitis (the predominant clinical context). Let me now search for more detailed ENT content and also vulvar vestibulitis content, plus supplementary web search.

Finding Sources

Searching the Web

nasal vestibulitis clinical features management 2024

Now let me also search for vulvar vestibulitis (vestibulodynia) in the gynecology textbook, and search for any relevant clinical images.

Reading File

Searching Images

nasal vestibulitis infection folliculitis furuncle nose

Clinical photography of a single nasal skin lesion showing an acute furuncle (boil) on the nasal vestibule/dorsum. The image depicts a solitary, erythematous, dome-shaped nodule with a shiny surface and surrounding mild edema. A palpable tenderness is suggested by the lesion’s conspicuous inflamed halo. A central pustule or crust may be present at the core, consistent with progression toward abscess formation within a pilosebaceous follicle. The lesion is located on the external nasal skin near the nostril, with frontal/anterior perspective offering clear visualization of the nasal bridge region. The clinical diagnosis is furunculosis of the nose, most often caused by Staphylococcus aureus; in this case PVL (Panton-Valentine leukocidin)–producing strains are implicated, which are associated with more aggressive skin and soft tissue infections and a higher risk of complications. Imaging is not radiologic; this is a dermatologic/clinical photograph used for documentation, teaching, and correlating with microbiology culture results. Management implications include incision and drainage if fluctuant, culture to guide antibiotics, and consideration of toxin-producing strains. The image serves educational purposes for dermatology, infectious disease, microbiology, and medical training in recognizing PVL-associated nasal furunculosis and differentiating it from impetigo, cellulitis, and Sty.

This is a clinical dermatology photograph of the nasal region illustrating Trichostasis spinulosa. Modality and technique: digital clinical photography, close-up macro view under standard white-light illumination. The image shows the nose with numerous tiny follicular papules; many dilated follicular openings contain bundles of fine vellus hairs that emerge from a single pore, producing characteristic hair tufts. Surrounding skin may show mild erythema or scale, but there is no overt inflammation. The distribution is localized to the nasal skin (dorsum and tip) and reflects a benign follicular disorder where multiple hair shafts are retained within a single follicle. Diagnostic significance lies in distinguishing TPS from acneiform lesions and folliculitis, guiding appropriate management rather than antimicrobial therapy. Clinically relevant use cases include dermatology education, image-based case discussions, and database curation for machine learning models aimed at recognizing hair-containing follicular disorders. This image captures the hallmark feature of TPS: multiple hair shafts within one follicular opening on nasal skin, contributing to its cosmetic appearance and patient counseling considerations.

This clinical photograph shows a close-up view of the human nose exhibiting signs of vascular compromise and secondary infection following a dermatological procedure. The primary pathology is localized to the nasal tip and dorsum, where a cluster of small, raised, erythematous pustules is prominently visible. These lesions are characterized by a rounded morphology and a deep red to violaceous hue, suggesting intense underlying inflammation and possible infection. The skin of the nasal bridge appears edematous and displays a shiny texture with diffuse erythema extending towards the glabella. In contrast, the skin on the adjacent cheeks maintains a more normal tone and texture, highlighting the localized nature of the inflammatory process. The visual findings are consistent with an infection state and impending tissue necrosis, likely resulting from vascular occlusion post-filler injection. This image serves as a clinical reference for identifying early progression from ischemic stages to pustule formation and potential eschar development in aesthetic medicine complications.

High-resolution clinical photograph of the left nasal ala and midface showing multiple skin-colored to slightly erythematous follicular papules with conspicuous comedo-like plugs along the nasal dorsum and alar rims. The image demonstrates numerous small keratotic plugs within dilated hair follicles, producing a pattern reminiscent of open comedones but clustered centrally on the nose. The underlying process is trichostasis spinulosa, a folliculocentric condition in which several vellus hairs are retained within a single follicular unit and obstructed by keratinous material. Lesion distribution is centrofacial, with highest density on the nose and mild textural coarsening of adjacent skin. The epidermis shows mild hyperkeratosis without overt pustulation or crusting; pigmentation is variable in some areas. Differential diagnoses include acne vulgaris with comedones, keratosis pilaris rubra faceii, and superficial folliculitis. Clinically, recognizing trichostasis spinulosa is important to avoid mislabeling as acne and to guide management toward follicular clearance. Treatment considerations include topical keratolytics (retinoids such as adapalene or tretinoin, benzoyl peroxide), gentle extraction, and adjunctive exfoliation; persistent cases may benefit from laser hair removal or chemical depilation. Image enhances educational awareness of centrofacial follicular occlusion disorders. This image provides a reference for clinicians diagnosing follicular occlusion disorders and tailoring patient education.

Searching PubMed

nasal vestibulitis treatment antibiotics

Excellent - I found a systematic review (PMID 36373460) directly on nasal vestibulitis. Let me get its abstract and also fetch the key clinical image.

Reading Article

PMID: 36373460

Loading Image

For ent subject of mmbs

I have all the information needed from the previous research session. Here is a comprehensive MBBS ENT-focused answer on Nasal Vestibulitis.

Nasal Vestibulitis - ENT (MBBS)

Definition

Nasal vestibulitis (NV) is a localized infection of the hair-bearing skin of the nasal vestibule - the area just inside the nostrils at the entrance to the nasal cavity. It commonly involves the hair follicles (folliculitis) of the vestibular skin.

Anatomy Reminder

The nasal vestibule is the most anterior part of the nasal cavity, lined by keratinized stratified squamous epithelium (skin) bearing vibrissae (coarse hairs). This is in contrast to the rest of the nasal cavity lined by respiratory mucosa. The skin here is susceptible to follicular infection.

Etiology / Causative Organism

Primary organism: Staphylococcus aureus (most common, both MSSA and MRSA)
Less common: Streptococcal species, fungal infections
Herpetic (HSV) infections - typically more severe and acute rather than chronic

Risk Factors (Common Exam Point)

Category	Examples
Local trauma	Nose picking, nasal hair plucking, excessive nose blowing
Iatrogenic	Nasal steroid sprays (though no confirmed association), nasal surgeries, cauterization
Chemotherapy	Taxanes (paclitaxel, nab-paclitaxel), bevacizumab - >75% develop nasal symptoms
Systemic	Diabetes mellitus, immunosuppression, obesity
Miscellaneous	Nasal piercing, nasal foreign body, poor hygiene

Clinical Features

Symptoms

Anterior nasal pain (often the presenting complaint)
Swelling and tenderness at the nasal tip / ala
Nasal crusting
Bleeding (epistaxis - minor)
Pustule formation just inside the nostril
Chronic irritation with recurrent symptoms in some patients

Signs on Examination

Erythema, cracking, and yellow crusting just inside the nostril
Mild erythema of the vestibular skin
Tenderness to palpation or movement of the nose
Nasal septum is typically spared (disease limited to vestibular skin/hair follicles)
May appear fairly normal in low-grade chronic cases

Spectrum of Disease (Important Classification)

1. Simple Vestibulitis (Folliculitis)

Superficial infection of hair follicles
Mild erythema, crusting, tenderness
Localized to vestibule

2. Furunculosis (Furuncle / Boil)

Deep variety of vestibulitis
Perifollicular erythema + edema
Possible abscess formation (pustule with fluctuation)
More severe pain and swelling

3. Carbuncle

A group/cluster of furuncles coalescing together
More extensive and severe

Non-infective Vestibulitis

Caused by physical/chemical irritation
No pus or organisms
Dryness, cracking, crusting without frank infection

Complications (High-Yield for Exams)

This is the most feared aspect of nasal vestibulitis - the "danger triangle of the face" concept:

Nasal Vestibulitis
        ↓
  Untreated / Severe
        ↓
  Facial Cellulitis
        ↓
  Cavernous Sinus Thrombosis  ← MOST DANGEROUS
        ↓
  Meningitis / Brain Abscess

The facial veins (angular vein, ophthalmic vein) are valveless and communicate with the cavernous sinus, enabling retrograde spread of infection.

Other complications:

Nasal tip cellulitis
Periorbital cellulitis
Septicemia (in immunocompromised)

Diagnosis

Clinical diagnosis - based on history and examination
No special tests usually needed
Nasal swab culture - indicated when:
- Symptoms recur or persist
- MRSA suspected
- Systemic involvement
- Immunocompromised patient
Cultures from abscess yield positive results in ~83% of cases (predominantly MSSA)

Management

A. Non-infective Vestibulitis

Vaseline (petroleum jelly) applied to vestibule - moisturizes and protects
Mild topical corticosteroid to reduce inflammation
Avoid precipitating factors (nose picking, excessive blowing)

B. Infective Vestibulitis - Mild/Moderate (Outpatient)

Step 1 - Topical antibiotics (first line):

Agent	Notes
Mupirocin (Bactroban nasal)	Drug of choice; also used for MRSA decolonization
Chlorhexidine + Neomycin (Naseptin)	First-line combination; contraindicated in peanut allergy (contains arachis oil); contraindicated in pregnancy
Bacitracin, Polymyxin	Alternative topical agents
Retapamulin	Alternative topical

Applied 3 times a day for 5 days
Warm compresses help reduce inflammation

Step 2 - Oral antibiotics (if topical insufficient or moderate disease):

Amoxicillin-clavulanate - most commonly used
Clindamycin - for penicillin allergy or as second-line
Anti-staphylococcal agents (flucloxacillin, dicloxacillin)

C. Severe / Complicated Cases (Inpatient)

Indications for admission:

Treatment failure in outpatient setting
Presence of cellulitis or abscess
Immunocompromised patient
Signs of spreading infection

Treatment:

IV antibiotics (IV amoxicillin-clavulanate is most common)
Incision and drainage (I&D) - for fluctuant abscess
Add antiviral (valacyclovir) if herpetic infection suspected

D. MRSA Eradication Protocol

Mupirocin is the second-line agent for MRSA
Applied 3 times daily for 5 days
A swab is taken 2 days after completion to confirm MRSA eradication

E. Chemotherapy-associated Nasal Vestibulitis

Saline nasal sprays - basic supportive care
Rose geranium in sesame oil nasal spray - evidence supports superiority over saline

Clinical Image

Nasal furuncle - erythematous nodule at nasal vestibule, typical of vestibular furunculosis caused by S. aureus

Furuncle (boil) at the nasal vestibule - erythematous, dome-shaped lesion with central pustule. This is the deep variety of vestibulitis caused by S. aureus, with risk of cavernous sinus thrombosis if untreated.

High-Yield Summary Table for MBBS Exams

Feature	Detail
Organism	S. aureus (MSSA > MRSA)
Risk factors	Nose picking, hair plucking, DM, immunosuppression
Classic symptom	Anterior nasal pain + crusting + tenderness
Septum involvement	Usually spared
Deep form	Furunculosis (abscess)
Multiple furuncles	Carbuncle
Dangerous complication	Cavernous sinus thrombosis
First-line topical Rx	Mupirocin OR Naseptin
MRSA treatment	Mupirocin
Naseptin contraindication	Peanut allergy, pregnancy
Oral antibiotic	Amoxicillin-clavulanate
I&D indication	Fluctuant abscess

Sources

K.J. Lee's Essential Otolaryngology - Nasal Vestibulitis section
Scott-Brown's Otorhinolaryngology Head & Neck Surgery Vol. 1 - Vestibulitis section
Harrison's Principles of Internal Medicine 22E (2025) - Nasal Vestibulitis
Textbook of Family Medicine 9e - Nasal Vestibulitis
Marra P et al. Nasal Vestibulitis and Vestibular Furunculosis: a systematic review. Clin Ter. 2022 (PMID: 36373460)

Clinical features and management of chronic rhinosinusitis for ent subject with deep from standard textbooks

The skill was already read in the previous session. Launching all searches in parallel now.

Finding Sources

Searching PubMed

"chronic rhinosinusitis" diagnosis management guidelines

Excellent - found key sections in Cummings, Scott-Brown's, KJ Lee, Harrison's, and Goldman-Cecil. Now reading all the major sections in parallel.

Reading File

Searching Images

chronic rhinosinusitis nasal polyps endoscopy CT scan sinusitis

This composite clinical image presents a side-by-side comparison of diagnostic modalities for chronic rhinosinusitis (CRS). On the left, a coronal CT scan of the paranasal sinuses shows significant soft tissue opacification in the bilateral maxillary and ethmoid sinuses, indicating a positive diagnosis for sinusitis according to Lund-Mackay staging criteria. The nasal septum is centered, and inferior turbinates are visible. On the right, a corresponding nasofibroscopy (endoscopy) frame provides a direct view of the nasal passage and mucosa. In this specific case, the endoscopic view appears negative for classic signs of CRS, demonstrating smooth mucosa without evident purulent secretion, polyps, or significant edema in the visible meatus. The pairing illustrates a clinical 'disagreement' where radiologic evidence suggests disease that is not immediately visible via endoscopy, highlighting the diagnostic complexity of sinonasal pathology in otolaryngology.

This composite figure displays diagnostic findings of chronic rhinosinusitis with nasal polyps (CRSwNP). Image A is a nasal endoscopy showing a large, pale-pink, fleshy nasal polyp occupying the middle meatus and partially obstructing the nasal passage. Key landmarks include the nasal septum (NS) on the medial side and the inferior nasal turbinate (INT) at the inferior aspect. Image B is a coronal non-contrast CT scan of the paranasal sinuses. It reveals partial opacification and mucosal thickening within the bilateral maxillary, ethmoid, and frontal sinuses. The soft tissue density lesions signify inflammatory polyposis and retained secretions, though significant aeration is visible compared to total opacification. The nasal septum is midline, and the turbinate structures are clearly delineated. These images demonstrate the clinical and radiological presentation of eosinophilic chronic rhinosinusitis (ECRS) and are used to assess the Total Polyp Score (TPS) and Lund-Mackay Score (LMS) in response to treatment, such as biologics like dupilumab.

This composite figure illustrates the clinical and radiological response to treatment for eosinophilic chronic rhinosinusitis (ECRS) in an adult patient. Panel A displays a right-sided nasal endoscopy view showing a persistent, smooth, pale yellow-colored polypoid mass located within the olfactory fissure (marked by a white arrow). Panel B presents a left-sided nasal endoscopy view showing resolution of previously documented nasal polyps, with visible nasal mucosa and patent passages. Panel C is a coronal paranasal sinus CT scan following four months of therapy, demonstrating significant improvement in sinus aeration. The black, air-filled spaces within the maxillary, ethmoid, and frontal sinuses indicate reduced mucosal thickening and clearance of soft-tissue opacities, although residual mucosal thickening remains visible in the floor of the maxillary sinuses. Collectively, the images provide a comparison of endoscopically visible localized disease versus global sinus improvement monitored via diagnostic imaging.

A multi-modal comparison of Chronic Rhinosinusitis without Nasal Polyps (CRSsNP) and with Nasal Polyps (CRSwNP). The image is divided into two clinical panels, each containing endoscopy, CT imaging, and histopathology. The CRSsNP panel (left) shows endoscopic nasal mucosal thickening, a coronal CT scan with ethmoid sinus opacification, and a light microscopy image (H&E, x100) labeled 'FIBROSIS'. This state is characterized by high levels of IFN̳, TGF̲1, and Activin A, and a low Follistatin/activin A ratio. The CRSwNP panel (right) displays endoscopic visualization of translucent nasal polyps, a coronal CT scan showing extensive sinus opacification, and a histopathological image (EG2, x100) labeled 'EDEMA'. It highlights eosinophilic infiltration (red staining) with high levels of IL-5 and ECP, but low TGF̲1 and Activin A. This comparison illustrates the different tissue remodeling patterns in CRS: predominant fibrosis and Th1/pro-fibrotic markers in CRSsNP versus predominant edema and Th2 markers in CRSwNP.

Educational visual panel depicting a rabbit model of chronic rhinosinusitis (CRS) at 14 weeks. (A) Coronal micro-CT scan of the paranasal sinuses demonstrating partial opacification of the left maxillary and ethmoid sinuses (yellow asterisks), indicating fluid or mucosal thickening. (B) Nasal endoscopy image showing the left middle meatus with purulent secretions (yellow arrow) positioned between the middle turbinate and the lateral nasal wall. (C) H&E stained histopathology slide showing significant infiltration of chronic inflammatory cells (plasma cells and lymphocytes), epithelial hyperplasia, and submucosal edema. (D) Periodic Acid-Schiff (PAS) stained comparison between control (upper) and chronic sinusitis (lower) tissue. The chronic group exhibits marked hypertrophy and increased density of submucous glands, staining deep purple, which characterizes mucus hyperplasia. This composite illustrates diagnostic imaging, clinical findings, and microscopic cellular changes associated with long-term sinus inflammation.

Excellent content coming in. Now let me read more detailed sections - Cummings block 10 (management), KJ Lee, and Scott-Brown's polypoidal CRS section.

Reading File

Good content. Now let me get the detailed CRS pathophysiology and management from Cummings block 9 (which has the most detailed CRS chapter) and read Scott-Brown's full CRS section.

Reading File

Loading Image

Now let me get the key CRS pathophysiology/clinical features from Cummings (the definitive ENT textbook) and also fetch the CRSsNP vs CRSwNP comparison image.

Finding Sources

Loading Image

I now have rich content from all major textbooks plus excellent images. Let me get one more key section on EPOS diagnostic criteria and medical management from Cummings.

Finding Sources

Let me read the detailed Cummings CRS chapter (block 9, earlier section) which should have the clinical features and pathophysiology.

Reading File

I have sufficient, rich content from multiple authoritative textbooks. Let me now compile the comprehensive answer.---

Chronic Rhinosinusitis (CRS) - ENT (MBBS)

Sourced from: Cummings Otolaryngology, Scott-Brown's Otorhinolaryngology Vol.1, K.J. Lee's Essential Otolaryngology, Harrison's Principles of Internal Medicine 22E, Goldman-Cecil Medicine

Definition

Chronic Rhinosinusitis (CRS) is inflammation of the nose and paranasal sinuses lasting more than 12 consecutive weeks, characterized by two or more cardinal symptoms, with objective evidence of mucosal inflammation on endoscopy or CT.

"CRS is diagnosed when symptoms last more than 12 consecutive weeks." - Cummings Otolaryngology

Classification (High-Yield)

CRS is broadly subcategorized into two major phenotypes:

Feature	CRS without Nasal Polyps (CRSsNP)	CRS with Nasal Polyps (CRSwNP)
Sex predominance	More common in women	More common in men
Age of onset	Childhood / young adulthood	Adulthood
Inflammation type	TH1-mediated, IFN-γ dominant	TH2-mediated, eosinophilic
Histology	Fibrosis, BM thickening, goblet cell hyperplasia, mononuclear infiltrate	Edematous stroma, albumin deposition, pseudocyst formation, eosinophilic infiltrate
Key cytokines	IFN-γ high; TGF-β1 high	IL-5 high; ECP (eosinophil cationic protein) high
Presenting symptom	Facial pain/pressure dominant	Decreased/loss of smell dominant
Associations	Bacterial infection/colonization, deviated septum	Asthma, aspirin sensitivity (Samter triad), AFRS

Subtypes of CRS:

CRSsNP - without polyps
CRSwNP - with nasal polyps (most common polypoidal form)
Allergic Fungal Rhinosinusitis (AFRS) - associated with polyps; IgE-mediated; characteristic "peanut butter" greenish-brown mucus
Pediatric CRS

Pathophysiology

The ostiomeatal complex (OMC) is the key anatomical unit. Obstruction of the OMC leads to:

OMC Obstruction
      ↓
Impaired mucociliary clearance + Reduced ventilation
      ↓
Mucus stasis + Bacterial colonization
      ↓
Persistent mucosal inflammation
      ↓
Chronic Rhinosinusitis

Proposed aetiological mechanisms (Scott-Brown's):

Bacterial superantigen response (Staphylococcal enterotoxins)
Fungal sensitization
Atopy and allergens
Biofilm formation (polymicrobial - S. aureus, P. aeruginosa)
Osteitis (bone remodeling)
Unified airway disease (association with lower airway disease)

CRSwNP: TH2-skewed eosinophilic inflammation with high IL-5 and ECP in polyps
CRSsNP: TH1 milieu with increased IFN-γ in inflamed mucosa and fibrotic remodeling

Endoscopy and CT Imaging Comparison: CRSsNP vs CRSwNP

CRSsNP vs CRSwNP - endoscopy, CT scan, and histopathology comparison showing fibrosis (TH1/IFN-γ) in CRSsNP vs edema and eosinophilic infiltration (TH2/IL-5/ECP) in CRSwNP

Left: CRSsNP showing mucosal thickening and fibrosis. Right: CRSwNP showing translucent nasal polyps, extensive sinus opacification, and eosinophilic edema on histology.

Clinical Features

Cardinal Symptoms (EPOS Diagnostic Criteria)

Diagnosis requires 2 or more of the following, present for >12 weeks:

Nasal obstruction / congestion (blockage)
Nasal discharge - anterior rhinorrhea or postnasal drip (may be mucopurulent)
Facial pain / pressure / fullness
Reduction or loss of smell (hyposmia/anosmia) - more prominent in CRSwNP

"Cardinal symptoms: facial pain or pressure, nasal discharge or postnasal drip, congestion, and hyposmia or anosmia." - Harrison's Principles 22E

Additional/Associated Symptoms:

Fatigue and malaise
Ear pressure / fullness
Hoarseness (from postnasal drip)
Chronic cough
Headache
Sleep disturbance

Sinus-Specific Pain Locations:

Sinus	Pain Location
Maxillary	Cheek, upper teeth, infraorbital region
Frontal	Forehead, supraorbital area
Ethmoid	Between eyes, medial canthal region, bridge of nose
Sphenoid	Vertex of skull, occiput, retro-orbital ("worst headache")

Signs on Examination:

Anterior Rhinoscopy:

Mucosal erythema and edema
Mucopurulent discharge in the middle meatus
Nasal polyps: pale/grey/yellow translucent growths in middle meatus (in CRSwNP)
Nasal septal deviation (predisposing factor)

Nasal Endoscopy (gold standard for examination):

Mucosal disease in middle meatus and ethmoid bulla
Purulent secretions from sinus ostia
Polyps visualized
Posterior disease (sphenoid/posterior ethmoid) not visible on anterior rhinoscopy

Nasal Polyps: Key Features

Nasal endoscopy (A) showing pale nasal polyp in middle meatus, with coronal CT (B) showing bilateral sinus opacification in CRSwNP

Left: Endoscopic view of nasal polyp (labeled "Polyp") in middle meatus, with nasal septum (NS) and inferior turbinate (INT). Right: Coronal CT showing bilateral sinus opacification typical of CRSwNP.

Appear as white, grey, tan, or yellow translucent growths
Arise from the middle meatus (bilateral and multiple in CRSwNP)
Pale and insensate (do not bleed on probing - differentiates from turbinate hypertrophy)
Unilateral polyp = always suspect malignancy (inverted papilloma, SCC, especially in older patients / wood-dust exposure)

Samter's Triad (Aspirin-Exacerbated Respiratory Disease - AERD):

Nasal polyposis + Bronchial asthma + Aspirin/NSAID sensitivity

Investigations

1. Nasal Endoscopy

Best for confirming mucosal inflammation in middle meatus and posterior areas invisible on anterior rhinoscopy
Visualizes polyps, purulent secretions, anatomical variants

2. CT Paranasal Sinuses (Non-contrast) - Imaging of Choice

Coronal cuts are most informative (shows OMC anatomy clearly)
Findings in CRS:
- Diffuse or polypoid mucosal thickening
- Partial or complete opacification of sinuses
- Bone remodeling/thickening (osteitis)
- Intrasinus calcifications
- OMU obstruction (infundibular, OMC, or sphenoethmoidal recess patterns)
Chronic secretions: increased density (30-60 HU) vs acute (10-25 HU)
40% of patients with symptom-based CRS have normal CT - objective confirmation is mandatory

Lund-Mackay Scoring System (CT scoring for CRS):

Each sinus scored 0 (clear), 1 (partial opacification), 2 (complete opacification)
OMC scored 0 or 2
Maximum total score: 24

3. Nasal Swab / Culture

To identify organisms and antibiotic sensitivity
Important in recurrent/recalcitrant cases

4. Allergy Testing

Skin prick test or RAST - important especially in CRSwNP

5. MRI

Not routine; used when malignancy, fungal disease, or intracranial extension suspected
Superior to CT for soft tissue differentiation

6. Special Tests (when indicated):

Saccharin test / Ciliary biopsy - if primary ciliary dyskinesia suspected
Sweat chloride test / CFTR mutation - if cystic fibrosis suspected
Immunoglobulin levels - if immunodeficiency suspected
ANCA, ACE levels - if granulomatous disease (Wegener's, sarcoid) suspected

Management

Step 1 - General/First-Line Medical Management

A. Saline Nasal Irrigation

High-volume saline washes (e.g., Neil Med, Neti pot) - more effective than simple sprays
Clears mucus, promotes drainage, reduces mucosal edema
Safe, well-tolerated, used in all subtypes

B. Intranasal Corticosteroids (INCS) - Mainstay of Treatment

Mometasone, Fluticasone, Budesonide (sprays or rinses)
Reduce mucosal edema and polyp size
High-volume budesonide rinses have superior evidence vs standard sprays for CRSwNP
Should be tried for at least 4 weeks by primary care before ENT referral (EPOS guidelines)
Excellent safety profile; minimal systemic absorption

C. Antibiotics

Role is limited in CRS; not first-line
Macrolides (e.g., clarithromycin, azithromycin) for 3 months - modest quality evidence supports use in CRSsNP without polyps (anti-inflammatory + antibacterial mechanism)
Short-course antibiotics (2-4 weeks) frequently prescribed but little evidence of benefit
Biofilm-forming organisms (S. aureus, P. aeruginosa) lead to resistance
Antifungal agents: NOT recommended for any subtype of CRS

D. Oral Corticosteroids

Short course (2-3 weeks) for CRS unresponsive to intranasal steroids
Especially effective for CRSwNP (shrinks polyps temporarily)
Used as "rescue" or bridging therapy

E. Antihistamines

For patients with allergic component (IgE-mediated disease)
Intranasal or systemic

F. Leukotriene Antagonists

Montelukast - particularly helpful when allergic component present
Useful adjunct in AERD/aspirin sensitivity

G. Decongestants

Used sparingly and briefly only (risk of rhinitis medicamentosa with prolonged use)

Step 2 - Second-Line / Escalated Medical Management

Biologic Therapies (for Severe, Recalcitrant CRSwNP)

Modern targeted biologics - approved for severe CRSwNP inadequately controlled by surgery + medical therapy:

Biologic	Mechanism	Target
Dupilumab (FDA approved)	Anti-IL-4Rα (blocks IL-4 + IL-13)	Type 2 inflammation
Mepolizumab	Anti-IL-5	Eosinophil reduction
Benralizumab	Anti-IL-5Rα	Eosinophil depletion
Omalizumab	Anti-IgE	Allergic pathway

Meta-analysis (PMID: 39729039) confirms budesonide nasal irrigation benefits for CRS
Biologics reduce polyp size and symptom burden, improving QOL

Step 3 - Surgical Management

Indications for Surgery:

Failure of appropriate maximal medical therapy (most common indication)
CT-confirmed residual disease after medical treatment
Complications of CRS
Suspected malignancy
Antrochoanal polyp (relative indication)

"CRS that is recalcitrant to medical therapy is the most common indication for surgery." - Cummings Otolaryngology

Functional Endoscopic Sinus Surgery (FESS) - Surgery of Choice

Principles of FESS:

Mucosal preservation (Messerklinger technique)
Restoration of ventilation and drainage
Removal of obstructing disease while preserving normal structures
Provides wide passages for topical drug delivery post-operatively

Goals of FESS in CRSsNP:

Relieve obstruction at OMC
Restore mucociliary clearance
May be curative in some subtypes (e.g., odontogenic sinusitis)

Goals of FESS in CRSwNP:

Remove polyps and debris
Complete ethmoidectomy (most critical step)
Create wide sinus openings for topical medication delivery
Surgery adjunctive - long-term medical therapy still required post-FESS

Common FESS procedures:

Uncinectomy (removal of uncinate process)
Middle meatal antrostomy (maxillary sinus opening)
Anterior ethmoidectomy
Posterior ethmoidectomy
Sphenoidotomy
Frontal sinusotomy (Draf procedures for frontal sinus)

Other Surgical Options:

Polypectomy - simple removal; often combined with FESS
Caldwell-Luc operation - now largely obsolete; reserved for specific indications
Adenoidectomy - effective in pediatric CRS

Pre-surgical Requirements (Scott-Brown's):

CT scan must be obtained to:
- Assess residual disease
- Identify anatomical risk factors
- Plan surgical approach
Informed consent including:
- Natural history of disease
- Surgical complications (orbital, intracranial injury)
- Risk of recurrence
- Need for ongoing medical management

Special Associations (High-Yield)

Samter's Triad (AERD):

Nasal polyposis + Asthma + Aspirin/NSAID sensitivity
Treatment: salicylate desensitization therapy

Allergic Fungal Rhinosinusitis (AFRS):

Occurs in 20s-30s; warm, humid regions; atopic patients
Characteristic mucus: thick, greenish-brown, peanut butter consistency with fungal hyphae (Aspergillus)
CT: double-density sign, often unilateral, can expand sinus walls
Resistant to medical therapy; surgery + perioperative steroids is treatment of choice

Cystic Fibrosis:

Nearly universal CRS and nasal polyps
Young patients with bilateral polyps should be tested

Primary Ciliary Dyskinesia (Kartagener's syndrome):

CRS + bronchiectasis + situs inversus
Defective cilia - impaired mucociliary clearance

Granulomatous Disease:

Granulomatosis with polyangiitis (Wegener's): ANCA positive; saddle nose deformity
Sarcoidosis: lupus pernio, non-caseating granulomas

Complications of CRS

Category	Complications
Orbital (most common)	Periorbital edema, orbital cellulitis, subperiosteal abscess, orbital abscess, cavernous sinus thrombosis
Intracranial	Meningitis, epidural abscess, subdural empyema, brain abscess
Osseous	Osteomyelitis, Pott's puffy tumour (frontal bone osteomyelitis)
Local	Mucocele, mucopyocele

Key High-Yield Summary Table

Feature	Detail
Definition	>12 weeks of rhinosinusitis symptoms
Cardinal symptoms	Obstruction, discharge, facial pain/pressure, hyposmia/anosmia (≥2 needed)
Imaging of choice	Non-contrast CT PNS (coronal cuts)
Best for diagnosis	Nasal endoscopy + CT (combined)
CRSsNP inflammation	TH1, IFN-γ, fibrosis
CRSwNP inflammation	TH2, IL-5, ECP, eosinophilic edema
Polyp appearance	Pale, grey, translucent; insensate; bilateral (middle meatus)
Unilateral polyp	Suspect malignancy / inverted papilloma
Mainstay medical Rx	Intranasal corticosteroids + saline irrigation
Antibiotics	Macrolides 3 months for CRSsNP; limited evidence overall
Antifungals	NOT indicated in standard CRS
Surgery	FESS (after failed medical therapy)
Samter's Triad	Polyps + Asthma + Aspirin sensitivity
AFRS mucus	Thick, peanut butter, greenish-brown
Pediatric CRS surgery	Adenoidectomy first-line
CT scoring	Lund-Mackay system
Biologic for refractory CRSwNP	Dupilumab (anti-IL-4Rα)

Sources

Cummings Otolaryngology Head and Neck Surgery - Chapters 38, 43, 44
Scott-Brown's Otorhinolaryngology Head & Neck Surgery Vol.1 - Chapter 94
Harrison's Principles of Internal Medicine 22E (2025) - Chronic Sinusitis
K.J. Lee's Essential Otolaryngology
Goldman-Cecil Medicine International Edition
Payne SC et al. Executive Summary - Clinical Practice Guideline on Adult Sinusitis Update. Otolaryngol Head Neck Surg. Aug 2025
Shin JJ et al. Clinical Practice Guideline: Surgical Management of CRS. Otolaryngol Head Neck Surg. Jun 2025
Magboul N et al. Budesonide nasal irrigation for CRS: meta-analysis. Rhinology. 2025

Investigation and surgical management of chronic rhinosinusitis

Searching sources...

Finding Sources

Searching PubMed

"chronic rhinosinusitis" surgical management endoscopic sinus surgery

Good start. Now reading the key textbook sections in parallel - Scott-Brown's FESS chapter, Cummings surgical chapter, and searching for Lund-Mackay/CT scoring.

Reading File

Finding Sources

Searching Images

FESS endoscopic sinus surgery procedure nasal endoscopy CT paranasal sinuses

Good content from Scott-Brown's FESS section and Cummings. Now reading more FESS surgical steps, complications, and investigation details.

Reading File

Finding Sources

Now reading FESS complications, post-op care, and getting Cummings investigation/imaging section.

Reading File

Searching Images

coronal CT paranasal sinuses ostiomeatal complex opacification chronic sinusitis

Excellent - I have the FESS surgical technique details including complications. Now I need post-op care, Draf procedures for frontal sinus, and investigation details. Let me read those sections.

Reading File

Loading Image

Excellent. Now reading the FESS post-op care, balloon sinuplasty details, and the Cummings section on CT patterns for investigation.

Reading File

Now I have the Lund-Mackay scoring details and CT patterns. Let me fetch the key CT image and read the surgical complications section fully.

Loading Image

Reading File

I now have comprehensive content from all the key textbooks. I have enough to write the full, detailed answer. Let me compile it now.

Investigation and Surgical Management of Chronic Rhinosinusitis

Sources: Cummings Otolaryngology (2019), Scott-Brown's Otorhinolaryngology Vol.1, K.J. Lee's Essential Otolaryngology, Harrison's Principles of Internal Medicine 22E, Goldman-Cecil Medicine

PART A: INVESTIGATIONS

Overview

"Almost all symptoms [of CRS] are nonspecific and without objective demonstration of mucosal inflammation; therefore the symptom-based diagnosis is unreliable. More than 40% of patients who fulfil the symptom-based diagnosis of CRS may have normal CT and endoscopy results." - Cummings Otolaryngology

Objective confirmation is mandatory. The two pillars of investigation are nasal endoscopy and CT of the paranasal sinuses.

1. Nasal Endoscopy

The gold standard for examining mucosal disease in CRS.

Anterior rhinoscopy is insufficient - only allows anterior nasal cavity visualization
Rigid nasal endoscopy (0°, 30°, 45° telescopes) visualizes:
- Middle meatus and ethmoid bulla (key area for CRS)
- Mucopurulent secretions from sinus ostia
- Mucosal edema, polypoid change
- Posterior nasal cavity and nasopharynx
- Sphenoethmoidal recess (posterior ethmoid/sphenoid area)

Endoscopic findings in CRS:

Mucosal edema and erythema in the middle meatus
Mucopurulent/purulent discharge from the middle meatus
Nasal polyps (pale, grey, translucent - bilateral in CRSwNP)
Loss of normal anatomical landmarks (turbinate hypertrophy, septal deviation)
Crust formation in post-surgical cases

Correlation: CT-endoscopy correlation is 70-80%. A positive endoscopy with negative CT can occur (chronic mucosal inflammation visible endoscopically), and CT positivity in asymptomatic individuals occurs in up to one-third of the population. Therefore both are needed together for reliable diagnosis.

2. CT Paranasal Sinuses (Non-Contrast) - Imaging of Choice

Preferred modality: Non-contrast CT in coronal plane (also axial; sagittal for frontal recess)

CT Findings in CRS (Cummings):

Diffuse or polypoid mucosal thickening (most common finding)
Partial or complete opacification of one or more sinuses
Bone remodeling and thickening (osteitis) - secondary reaction to chronic mucosal inflammation
Intrasinus calcifications (especially in fungal disease)
OMU (ostiomeatal unit) obstruction - blockage of infundibulum
Chronic secretions have increased attenuation: 30-60 HU (vs. acute: 10-25 HU)

CT of chronic rhinosinusitis: bilateral maxillary/ethmoid sinus opacification with scattered calcifications, intrinsic hyperdense secretions, and bony wall sclerosis/thickening (Cummings Otolaryngology)

CT of CRS: bilateral sinus opacification, hyperdense secretions, and bony wall sclerosis and thickening (osteitis). - Cummings Otolaryngology

Five CT Patterns of Sinusitis (Babbel Classification):

Pattern	Frequency	Description
Infundibular	26%	Obstruction at maxillary ostium/infundibulum → maxillary disease
OMU pattern	25%	Middle meatus obstruction → ipsilateral maxillary + frontal + anterior ethmoid disease
Sphenoethmoidal recess	6%	Sphenoid and/or posterior ethmoid disease
Sinonasal polyposis	Wide extent	Diffuse bilateral disease
Sporadic/unclassifiable	Remainder	No clear pattern

OMU pattern is the most clinically relevant - obstruction of the middle meatus causes simultaneous disease in maxillary, frontal, and anterior ethmoid sinuses
72% of CRS patients have middle meatus opacification
100% of frontal sinus inflammatory disease has opacification of the frontoethmoidal recess

Lund-Mackay CT Scoring System (Most Widely Used):

Sinus Subsite	Score
Each sinus (anterior ethmoid, posterior ethmoid, frontal, maxillary, sphenoid)	0 = clear; 1 = partial opacification; 2 = total opacification
Each ostiomeatal complex (OMC)	0 = patent; 2 = obstructed

5 sinuses × 2 sides = 10 subsites (max score 20)
1 OMC × 2 sides = 2 subsites (max score 4)
Maximum total Lund-Mackay score = 24
Higher scores correlate with greater disease burden and guide surgical planning

CT's Role in Surgical Planning:

Identifies anatomical variants that increase surgical risk (see below)
Maps the extent of disease and affected sinuses
CT must be available to the surgeon throughout the operation (Scott-Brown's)
Image-guided navigation systems (IGS) use CT data for intraoperative orientation

Important Anatomical Variants on CT:

Variant	Significance
Concha bullosa	Pneumatized middle turbinate; can narrow OMC
Paradoxical middle turbinate	Medially curved → narrows middle meatus
Haller cells (infraorbital cells)	Ethmoid cells over maxillary roof; narrow infundibulum
Onodi cells (sphenoethmoidal cells)	Posterior ethmoid cells surrounding the optic nerve - high surgical risk
Deviated nasal septum	Contributes to OMC obstruction
Atelectatic uncinate process	Apposed to orbital floor; obstructs infundibulum
Low-lying skull base / asymmetry	Increased risk of CSF leak during ethmoidectomy

3. MRI of Paranasal Sinuses

Not routine - used selectively when:

Malignancy suspected (soft tissue differentiation far superior to CT)
Intracranial extension suspected (meningitis, abscess)
Fungal sinusitis (characteristic MRI signal patterns)
Orbital complications

MRI signal characteristics of CRS secretions:

Watery/acute secretions: T1 hypointense, T2 hyperintense
Chronic thickened secretions: T1 variable (high in inspissated/proteinaceous secretions), T2 hypointense
Fungal concretions (mycetoma): T2 signal void (characteristic)

4. Nasal Swab / Endoscopically-Directed Culture

Directed culture from the middle meatus (endoscopically guided)
Organisms in CRS: Mixed flora; Staphylococcus aureus, Pseudomonas aeruginosa (especially post-surgery), Streptococcus pneumoniae, H. influenzae, Moraxella catarrhalis, anaerobes, MRSA
Important for recalcitrant, post-surgical, and immunocompromised cases
Guides targeted antibiotic therapy

5. Allergy Testing

Skin prick testing or specific IgE (RAST) - for atopic CRS
Particularly important in CRSwNP (TH2-dominant, eosinophilic disease)
Positive in ~50% of CRSwNP patients

6. Histopathology

Tissue from polyps or biopsies at FESS
Confirms eosinophilic vs non-eosinophilic CRS (affects prognosis and treatment)
Rules out malignancy in atypical presentations
Identifies granulomatous disease (sarcoidosis, GPA)

7. Special Investigations (Selected Cases)

Test	Indication
Saccharin transit time test	Mucociliary clearance screening
Ciliary biopsy + electron microscopy	Primary ciliary dyskinesia (PCD/Kartagener's syndrome)
Sweat chloride test / CFTR genotyping	Cystic fibrosis
Serum immunoglobulins (IgG, IgA, IgM, IgE)	Immunodeficiency
ANCA (c-ANCA / PR3-ANCA)	Granulomatosis with polyangiitis (Wegener's)
ACE level, serum calcium	Sarcoidosis
Nasal cytology	Eosinophilia, fungal elements
Total serum IgE + Aspergillus-specific IgE	Allergic fungal rhinosinusitis (AFRS)
Skin prick test for Aspergillus	AFRS

Investigation Algorithm

SYMPTOM-BASED DIAGNOSIS OF CRS
(≥2 cardinal symptoms for >12 weeks)
             ↓
   Anterior Rhinoscopy / Nasal Endoscopy
   (confirm mucosal disease)
             ↓
   ┌─────────────────────────────┐
   │ Trial of Medical Therapy    │
   │ (INCS + Saline for 4 weeks) │
   └────────────┬────────────────┘
                ↓
        Persistent Symptoms?
                ↓
    CT PARANASAL SINUSES (Non-contrast)
    → Confirm disease, Lund-Mackay score
    → Identify anatomical variants
    → Surgical planning
                ↓
     Selectively: MRI, Allergy testing,
     Cultures, Special investigations

PART B: SURGICAL MANAGEMENT

Indications for Surgery

CRS recalcitrant to appropriate medical therapy - most common indication
CT-confirmed persistent mucosal disease after maximal medical treatment
Complications of CRS (orbital, intracranial)
Suspected sinonasal malignancy
Mucocele / mucopyocele
Fungal sinusitis (mycetoma, AFRS, invasive fungal)
Odontogenic sinusitis (may be curative)
Antrochoanal polyp (relative indication)
Frontal: barotrauma, osteoma causing obstruction, osteomyelitis (Pott's puffy tumor)

"CRS that is recalcitrant to medical therapy is the most common indication for surgery. Surgery is adjunctive to medical therapy." - Cummings Otolaryngology

Pre-operative Assessment

Before surgery, confirm:

Adequate trial of medical therapy (minimum 4-8 weeks of INCS + saline)
CT scan obtained and available (mandatory - must be displayed throughout surgery)
Patient fitness - cardiorespiratory status, anticoagulation, comorbidities
Informed consent including:
- Natural history and recurrence risk
- Surgical complications (orbital, intracranial, vascular, nasal)
- Need for ongoing post-operative medical treatment (especially in CRSwNP)
- Option to continue non-surgical management

Functional Endoscopic Sinus Surgery (FESS)

FESS is the surgical procedure of choice for CRS.

Principles of FESS (Messerklinger/Stammberger Technique):

Mucosal preservation - remove disease while preserving functional mucosa
Restoration of ventilation and drainage via the natural ostia
Restoration of mucociliary clearance
Minimum necessary surgery - address the specific disease
For CRSwNP: creates wide passages for post-operative topical drug delivery - critical, as topical agents virtually cannot penetrate unoperated sinus cavities

Equipment:

0°, 30°, 45° rigid endoscopes (Karl Storz or similar)
Microdebrider (powered shaver) - mucosal-preserving tissue removal
Through-biting forceps (preferred over Blakesley-Wells to avoid tearing mucosa)
Back-biting forceps (for uncinate incision)
Freer's elevator (to identify uncinate)
Kerrison's punch, Kuhn curettes (frontal recess)
CT scan displayed on screen throughout surgery
Image guidance / navigation system (optional but increasingly used)

Anaesthesia:

General anaesthesia preferred in most Western centres
Laryngeal mask (LMA) preferred over ET tube unless aspiration risk
Total IV anaesthesia (TIVA) increasingly used (Remifentanil) - BIS monitoring recommended to prevent awareness
Local infiltration with vasoconstrictor (1:80,000 adrenaline ± cocaine) for haemostasis

FESS Surgical Steps (Stepwise)

Step 1: Uncinectomy

Identify the uncinate process (boomerang-shaped structure bordering the infundibulum)
Use Freer's elevator to identify the free edge
Use back-biting forceps for inferior incision (avoids orbital penetration - do NOT use sickle knife inferiorly)
Sickle knife safe superiorly (frontal process of maxilla protects the orbit)
Remove the uncinate to expose the ethmoid infundibulum and maxillary ostium

Step 2: Middle Meatal Antrostomy (Maxillary Sinusotomy)

After uncinectomy, the maxillary sinus natural ostium is identified
The ostium is enlarged posteriorly and inferiorly using back-biters or the microdebrider
Creates a wide window for drainage and access
Avoids anterior and inferior extensions (lacrimal duct anteriorly, inferior turbinate inferiorly)

Step 3: Anterior Ethmoidectomy

The ethmoid bulla is the largest anterior ethmoid cell - it is opened first
Use through-biting instruments (preferred over Blakesley-Wells)
Remove anterior ethmoid partitions progressively, cell by cell
Anterior ethmoidal artery lies in the suprabulllar recess (occasionally within bulla wall) - avoid microdebrider in this area

Step 4: Posterior Ethmoidectomy

The ground lamella of the middle turbinate marks the boundary between anterior and posterior ethmoid
Perforate the ground lamella in the infero-medial quadrant (avoids skull base and lamina papyracea injury)
Use roof of maxillary sinus as a floor guide (always below the skull base)
Caution: Onodi cell may contain the optic nerve - always know your position

Step 5: Sphenoidotomy

Natural sphenoid ostium is located in the sphenoethmoidal recess, medial to the superior turbinate, at the level of the antral roof
Identify by passing endoscope medial to superior turbinate (may need to resect inferior third of superior turbinate for access)
If ostium cannot be found: create artificial opening through posterior ethmoid, then extend medially to incorporate natural ostium
Always perforate in the infero-medial portion to avoid skull base injury

Step 6: Frontal Sinusotomy (Draf Procedures)

The Agger nasi cell is the key landmark for all frontal recess approaches
Remove posterior wall and roof of Agger nasi cell to expose the frontal recess
Remove Kuhn cells (frontal recess cells) using Kuhn curettes or Rosemann punch
Critical: Avoid circumferential mucosal injury in the frontal recess - causes scarring and stenosis
Extended frontal procedures (Draf classification):

Draf Procedure	Extent	Indication
Draf I	Removal of cells below frontal ostium	Mild frontal disease
Draf IIa	Unilateral frontal sinusotomy (between middle turbinate and lamina papyracea)	Standard frontal disease
Draf IIb	Unilateral - includes frontal sinus floor from septum to lamina papyracea	Recurrent frontal disease
Draf III (EMLP)	Bilateral - creates common frontal-nasal cavity opening; removes intersinus septum + nasal septum segment	Severe/recurrent frontal disease, mucocele, osteoma

Additional Surgical Procedures

Polypectomy

Simple avulsion (microdebrider or Tilley-Henkel forceps)
Always combined with FESS for CRSwNP - polypectomy alone has high recurrence
Histology mandatory on all polyp specimens

Antrochoanal Polyp Removal

Requires removal of both the nasal + antral portions
Middle meatal antrostomy approach (FESS) to remove antral origin
Sublabial/transcanine or inferior meatal approach as supplementary access in some cases
Traditional Caldwell-Luc with mucosal stripping NOT necessary
Low recurrence if completely removed including antral component

Caldwell-Luc Operation (Largely Obsolete)

External approach to maxillary sinus via sublabial incision through canine fossa
Creates bone window into the anterior maxillary sinus wall
Largely replaced by FESS - inferior results, more morbidity
Still used in: odontogenic sinusitis, severely contracted maxillary sinus, failed FESS, tumour resection

Balloon Sinuplasty (Balloon Catheter Dilation)

Balloon dilation of maxillary, frontal, and/or sphenoid ostia
Controversial - does not remove disease, only dilates ostia
Evidence shows 80.5% ostial patency maintained
Suitable for: mild CRSsNP, frontal ostia dilation, elderly/unfit patients
Not appropriate for CRSwNP, extensive disease, or anatomical correction

Image-Guided Surgery (Navigation)

Uses preoperative CT fused with real-time intraoperative position tracking
Increases safety for complex/revision cases, near skull base, optic nerve
Not a substitute for CT on screen; both should be used

Adenoidectomy

First-line surgery in pediatric CRS (done before FESS in children)
Effective in some children by removing reservoir of infection in the nasopharynx

Post-operative Management

Immediate (Day 0-2):

Nasal packing (various materials - Merocel, Rapid Rhino, Bismuth iodoform paraffin paste)
Topical vasoconstrictors (1:80,000 adrenaline ± cocaine) for bleeding
Antibiotics: only if mucopus found at surgery (swab taken intraoperatively); no evidence for routine prophylactic antibiotics
Oral prednisolone: 25 mg daily for 10 days (CRSwNP) - eosinophils persist up to 3 weeks in tissues; may need extended 3-week course for extensive eosinophilic disease (taper to avoid Addisonian crisis)

Early post-op (Weeks 1-6):

Nasal saline irrigation (high-volume) - debrides crust, promotes mucociliary function
Topical intranasal corticosteroids (spray or budesonide rinse)
Review at 7-10 days (endoscopic debridement of crusts, clots, synechiae)
Weekly review if concerns; fortnightly if stable
Sinus cavity fully healed by 6 weeks

Long-term (3 months+):

Routine INCS sprays + less frequent irrigations continued
3-month review post-operatively
Patients with eosinophilic CRS / CRSwNP: may need indefinite topical steroids to prevent polyp recurrence
Biologic therapy (dupilumab, mepolizumab) for severe recalcitrant CRSwNP post-FESS

Surgical Complications of FESS

"In the hands of experienced clinicians, reported complications are rare. Analysis of the literature reveals a range of significant complications between 0.3 and 22.4% (median 7.0%)." - Scott-Brown's

Minor Complications:

Bleeding/epistaxis (most common)
Nasal adhesions / synechiae (middle turbinate to lateral wall)
Crusting, infection
Failure to improve / disease recurrence

Major Complications (Serious - Must Know for Exams):

Complication	Cause	Management
Orbital haematoma	Breach of lamina papyracea	Recognize immediately; decompress orbit (remove LP, incise periorbita ± lateral canthotomy/cantholysis)
Medial rectus injury	Orbital fat exposed + continued manipulation; microdebrider risk	Ophthalmology review; late oculoplastics
Optic nerve injury	Intraorbital haematoma; Onodi cell dissection	IV steroids immediately; urgent ophthalmology consult
CSF leak	Skull base breach (cribriform plate area)	Identify and repair intraoperatively (fat plug, mucosal graft, fibrin glue)
Meningitis / intracranial abscess	Unrecognized CSF leak or skull base breach	Neurosurgical consult; IV antibiotics
Internal carotid artery injury	Sphenoid surgery with bony dehiscence	Pack sphenoid; anaesthetic resuscitation; endovascular stent
Anosmia	Olfactory filaments / cribriform area injury	Counselled pre-operatively
Epiphora	Nasolacrimal duct injury (during anterior antrostomy)	Dacryocystorhinostomy (DCR) if needed

Guiding principle: If excessive bleeding causes poor visualization, abandon the procedure and plan a second stage - continuing with a bloody field risks catastrophic complications.

Outcomes of FESS

From the UK national audit (Scott-Brown's):

3,000+ patients analysed
CRSwNP patients had better outcomes than CRSsNP following surgery
Revision surgery rates:
- 3.6% at 12 months
- 11.8% at 36 months
- 19% by 5 years (21% for CRSwNP; 15% for CRSsNP)
Eosinophilic CRS: greater clinical severity + higher recurrence post-operatively
"Full-house" FESS + post-operative steroid irrigations reduces recurrence risk in CRSwNP
FESS produces significant symptom improvement and QOL improvement for both CRSwNP and CRSsNP despite limited RCT evidence

Factors not affecting surgical outcome (contrary to expectation): Smoking, allergy status

Factors worsening surgical outcome: Asthma, AERD/aspirin sensitivity, eosinophilic disease, previous FESS

High-Yield Summary for MBBS Exams

Topic	Key Point
Imaging of choice	Non-contrast CT PNS, coronal cuts
CT scoring system	Lund-Mackay (max 24)
Key CT finding	Mucosal thickening, OMU obstruction, osteitis
CT attenuation (chronic)	30-60 HU (vs acute 10-25 HU)
CT-endoscopy correlation	70-80%
Endoscopy finding	Mucosal edema, purulent discharge from middle meatus, polyps
Surgery of choice	FESS (Functional Endoscopic Sinus Surgery)
Indication for surgery	Failed maximal medical therapy
First FESS step	Uncinectomy
Key landmark for frontal	Agger nasi cell
Ground lamella entry	Infero-medial quadrant (safe zone)
Risk in posterior ethmoid	Onodi cell → optic nerve
Risk in sphenoid	ICA dehiscence
Obsolete operation	Caldwell-Luc
Post-op oral steroid	Prednisolone 25 mg × 10 days (CRSwNP)
Routine prophylactic Abx	NOT recommended post-FESS
Most feared complication	ICA injury (catastrophic) / Optic nerve injury
CSF leak site	Cribriform plate vertical lamella
5-year revision rate	19% overall
Biologic for refractory CRSwNP	Dupilumab (anti-IL-4Rα)

Sources

Cummings Otolaryngology Head and Neck Surgery (2019) - Chapters 38 & 44
Scott-Brown's Otorhinolaryngology Head & Neck Surgery Vol.1 - Chapter 98 (FESS)
K.J. Lee's Essential Otolaryngology - CRS section
Harrison's Principles of Internal Medicine 22E (2025)
Shin JJ et al. Clinical Practice Guideline: Surgical Management of CRS. Otolaryngol Head Neck Surg. Jun 2025 (PMID: 40424072)
Tran T et al. Extent of ESS in CRS: Systematic Review & Meta-Analysis. Curr Allergy Asthma Rep. 2024 (PMID: 39249643)

Etiology and treatment of maxillary sinusitis with explanation at the end of answer

Searching sources...

Finding Sources

Searching PubMed

maxillary sinusitis etiology management treatment

No direct heading match - let me search more broadly for sinusitis and maxillary sinus anatomy/pathology sections.

Finding Sources

Found key sections. Let me now read those in parallel along with the Scott-Brown's and Harrison's sinusitis sections.

Reading File

Finding Sources

Searching Images

maxillary sinus anatomy teeth roots odontogenic sinusitis dental infection

Good - rich content in hand. Now reading KJ Lee ABRS sections, Scott-Brown's acute rhinosinusitis, and Harrison's sinusitis treatment.

Reading File

Finding Sources

Searching Images

maxillary sinus anatomy cross section coronal nasal cavity

$This diagnostic image set consists of three non-contrast Computed Tomography (CT) scans of the midface and paranasal sinuses, presented in axial, coronal, and sagittal planes. The axial view (left) displays the bilateral maxillary sinuses as large, air-filled (radiolucent) cavities lateral to the nasal cavity and posterior to the maxilla. The coronal view (top right) highlights the vertical relationship between the orbits superiorly, the nasal conchae centrally, and the maxillary sinuses. Inferiorly, the relationship between the sinus floor and the alveolar process is visible. The sagittal view (bottom right) provides a detailed cross-section of the maxilla, specifically illustrating the anatomical proximity of the maxillary molar and premolar tooth roots to the inferior cortical wall (floor) of the maxillary sinus. This anatomical relationship is critical for understanding risks of iatrogenic sinus effraction or oroantral communication during dental extractions. The images serve as an educational reference for normal sinus anatomy and the evaluation of the sinus floor thickness in relation to the dental apparatus.$

This diagnostic image set consists of three non-contrast Computed Tomography (CT) scans of the midface and paranasal sinuses, presented in axial, coronal, and sagittal planes. The axial view (left) displays the bilateral maxillary sinuses as large, air-filled (radiolucent) cavities lateral to the nasal cavity and posterior to the maxilla. The coronal view (top right) highlights the vertical relationship between the orbits superiorly, the nasal conchae centrally, and the maxillary sinuses. Inferiorly, the relationship between the sinus floor and the alveolar process is visible. The sagittal view (bottom right) provides a detailed cross-section of the maxilla, specifically illustrating the anatomical proximity of the maxillary molar and premolar tooth roots to the inferior cortical wall (floor) of the maxillary sinus. This anatomical relationship is critical for understanding risks of iatrogenic sinus effraction or oroantral communication during dental extractions. The images serve as an educational reference for normal sinus anatomy and the evaluation of the sinus floor thickness in relation to the dental apparatus.

This diagnostic image is a coronal cross-section from a Cone Beam Computed Tomography (CBCT) scan, focusing on the maxillary sinus and midface anatomy. The image demonstrates a standardized methodology for measuring sinus width for implantology or oral surgery planning. An orange horizontal linear measurement of 17.19 mm indicates the sinus width, spanning from the buccal wall to the palatal wall. This measurement is positioned at a specific vertical reference height of 10.00 mm, marked by a blue vertical line originating from the alveolar crest. Key anatomical landmarks visible include the nasal cavity, inferior nasal turbinates, the floor of the maxillary sinus, and the underlying alveolar process. The image serves as a clinical guide for evaluating pneumatization and available bone volume in the posterior maxilla, highlighting the use of fixed reference points (10 mm above the crest) to ensure reproducible radiographic measurements in preoperative assessments.

This composite image illustrates the workflow for creating a multi-material, 3D-printed educational model of the human nasal cavity and paranasal sinuses derived from CT data. Panel A shows a 3D digital rendering of seven sequential coronal slabs, color-coded to differentiate anatomical segments from the external nose to the posterior nasopharynx. Panel B displays the physical 3D-printed model, fabricated using dual polymers: a translucent, flexible material for soft tissues and a rigid, opaque material for bony structures. Panel C provides a detailed view of a single coronal cross-section of the physical model. Key anatomical landmarks are labeled, including the bilateral eye sockets (orbits), the intricate scrolls of the nasal turbinates, the vertical nasal septum dividing the airway, and the large maxillary sinuses situated inferior to the orbits. This model is designed for otolaryngology (ENT) education to demonstrate complex sinus anatomy, airflow pathways, and surgical considerations for conditions such as sinusitis or septal deviation.

Now let me get the Scott-Brown's acute rhinosinusitis (ARS) etiology and treatment section, Harrison's treatment for sinusitis, and the Berek & Novak's full treatment section.

Finding Sources

Reading File

Loading Image

Now let me get the Scott-Brown's section on ARS etiology and the Harrison's treatment section, and read the KJ Lee pathogenesis section from the beginning.

Reading File

Excellent - very rich content now. Let me read Harrison's treatment section and the final segment of the Berek & Novak's sinusitis section.

Reading File

I now have comprehensive, textbook-quality content from multiple sources. I have everything needed to write the full answer with the "explanation at the end" as requested. Let me compile this now.

Etiology and Treatment of Maxillary Sinusitis

Sources: K.J. Lee's Essential Otolaryngology, Harrison's Principles of Internal Medicine 22E (2025), Berek & Novak's Gynecology, Scott-Brown's Otorhinolaryngology Vol.1

Anatomy Recall (Foundation)

The maxillary sinus (antrum of Highmore) is the largest paranasal sinus. Key anatomical facts relevant to its sinusitis:

Drainage ostium located high on the medial wall (superomedially) - gravity-dependent drainage is poor
Ostium opens into the infundibulum → middle meatus (ostiomeatal complex)
Floor of the maxillary sinus lies in close proximity to the roots of the upper premolars (4th, 5th teeth) and first and second molars (6th, 7th teeth) - basis of odontogenic sinusitis
Supplied by the maxillary artery branches; innervated by V2 (maxillary division of trigeminal nerve)

CT of maxillary sinuses - axial, coronal, and sagittal views showing anatomy; sagittal view highlights proximity of molar tooth roots to the sinus floor - key to understanding odontogenic sinusitis

CT of maxillary sinuses (axial, coronal, sagittal). Note in the sagittal view: the molar tooth roots are immediately below the sinus floor - the anatomical basis of odontogenic maxillary sinusitis.

Classification

Maxillary sinusitis is classified by:

Category	Type	Duration
By duration	Acute	< 4 weeks
	Subacute	4-12 weeks
	Chronic	> 12 weeks
	Recurrent acute	≥4 episodes/year with symptom-free intervals
By etiology	Viral (AVRS)	Most common overall
	Bacterial (ABRS)	Superimposed on viral
	Fungal	Mycetoma, AFRS, invasive
	Odontogenic	Dental source
	Non-infective	Allergic, vasomotor, irritant

ETIOLOGY

1. Viral Causes (Most Common - >90% of Acute Cases)

Rhinovirus (most common)
Coronavirus, Adenovirus, Influenza virus, Parainfluenza virus, RSV
Acute viral rhinosinusitis (AVRS) is the most common form
Viral infection → mucosal edema → obstruction of the sinus ostium → impaired mucociliary clearance → stasis of secretions
Self-limiting: resolves in 7-10 days
Only <2% of viral sinusitis cases progress to bacterial superinfection (Harrison's)

2. Bacterial Causes (ABRS)

Primary pathogens (community-acquired):

Organism	Frequency
Streptococcus pneumoniae	Most common (~30-40%)
Haemophilus influenzae	Common (~30%)
Moraxella catarrhalis	Common (especially children)
Streptococcus pyogenes (Group A)	Less common
Staphylococcus aureus	Less common; important in chronic/post-surgical

Hospital-acquired / nosocomial:

Gram-negative organisms (Pseudomonas, Enterobacter, Klebsiella)
Occur in ICU patients, nasotracheal intubation, immunocompromised hosts
Often polymicrobial

Post-surgical / Chronic bacterial:

Staphylococcus aureus (including MRSA), Pseudomonas aeruginosa, Fusobacterium, Prevotella, Bacteroides (anaerobes), Corynebacterium, Proteus mirabilis, E. coli
Biofilm formation by S. aureus and P. aeruginosa → antibiotic resistance → recalcitrant disease

3. Odontogenic Causes (Unique to Maxillary Sinus)

Exclusively affects the maxillary sinus (due to proximity of upper tooth roots to the sinus floor)
Causes:
- Periapical abscesses of upper teeth (2nd premolar, 1st and 2nd molars most commonly)
- Oroantral fistula (after dental extraction)
- Dental implants
- Periodontal disease
- Post-oral surgery infections
Usually unilateral - key distinguishing feature
Anaerobic organisms predominate
Resolves with treatment of the causative tooth + sinus

"Odontogenic bacterial infections often result in unilateral maxillary sinusitis. Caused by tooth root/periapical abscesses, oroantral fistula, post-oral surgery infections (e.g., dental implants). Generally resolve with treatment of the affected tooth and sinus." - K.J. Lee's Essential Otolaryngology

4. Fungal Causes

a. Mycetoma (Fungal Ball):

Non-invasive accumulation of fungal hyphae (usually Aspergillus fumigatus) in the maxillary sinus
Occurs in immunocompetent individuals
Unilateral; CT shows hyperdense material with calcifications (double density sign)
Treatment: FESS removal (no antifungals needed for non-invasive type)

b. Allergic Fungal Rhinosinusitis (AFRS):

Young atopic patients (20s-30s)
Type I IgE-mediated hypersensitivity to fungal antigens
Bent-Kuhn criteria: nasal polyps + type I hypersensitivity + eosinophilic mucin (peanut butter-consistency) + characteristic CT + fungal stain/culture positive
Common fungi: Aspergillus, Bipolaris, Curvularia, Alternaria

c. Invasive Fungal Sinusitis:

Seen in immunocompromised patients (uncontrolled diabetes mellitus, neutropenia, transplant recipients, HIV)
Organisms: Mucorales (Mucor, Rhizopus) - causes rhinocerebral mucormycosis; Aspergillus
Medical emergency - rapidly progressive; can invade orbit, intracranial structures
Presentation: facial pain, headache, cranial nerve involvement, proptosis, chemosis, black necrotic eschar

5. Anatomical / Structural Causes

Predisposing factors that narrow or obstruct the ostiomeatal complex (OMC):

Deviated nasal septum - displaces middle turbinate, narrows middle meatus
Concha bullosa - pneumatized middle turbinate; narrows OMC
Haller cells (infraorbital ethmoid cells) - narrow the maxillary infundibulum directly
Turbinate hypertrophy - inferior or middle
Nasal polyps - obstruct drainage
Paradoxical middle turbinate
Sinonasal tumours - cause secondary obstruction

6. Mucociliary Dysfunction

Cystic fibrosis - altered Cl⁻/water transport → thick viscid mucus → poor clearance
Primary Ciliary Dyskinesia (PCD / Kartagener's syndrome) - immotile cilia
Cigarette smoking - impairs ciliary function
Decreased hydration - inspissated secretions

7. Allergic / Immunological Causes

Allergic rhinitis - type I hypersensitivity; eosinophilic mucosal inflammation; mucosal edema obstructs OMC
Aspirin-Exacerbated Respiratory Disease (AERD) - arachidonic acid pathway dysregulation
Immunodeficiency - hypogammaglobulinemia, IgA deficiency, HIV

8. Environmental / Miscellaneous Causes

Barotrauma - scuba diving, air travel (pressure changes cause mucosal edema and haemorrhage)
Atmospheric pollutants, tobacco smoke
Nosocomial - nasotracheal intubation, nasogastric tube (direct obstruction of OMC or local trauma)
Cold and damp weather
Systemic disease - connective tissue disorders, malnutrition, Wegener's granulomatosis (GPA), sarcoidosis

Pathogenic Mechanism: Common Pathway

Precipitating Factor (viral URTI, allergy, structural, dental)
               ↓
   Mucosal edema of nasal cavity / OMC
               ↓
   Obstruction of maxillary sinus ostium (high on medial wall)
               ↓
   Impaired ventilation + Mucociliary stasis
               ↓
   Hypoxia in sinus → O2 ↓, pH ↓
               ↓
   Bacterial colonization → Infection
               ↓
   Acute Maxillary Sinusitis
               ↓ (if untreated / recurrent)
   Chronic Maxillary Sinusitis

CLINICAL FEATURES (Brief Recap)

Symptoms of Acute Maxillary Sinusitis:

Facial pain/pressure over the cheeks (malar area) - worsens on bending forward
Maxillary toothache (upper premolars/molars) - referred via V2
Purulent nasal discharge (anterior or posterior)
Nasal obstruction/congestion
Fever, malaise, headache
Unilateral pain = suspect odontogenic or fungal

Signs:

Tenderness on pressure/percussion over the malar area
Purulent exudate in the middle meatus
Erythema/swelling of overlying cheek (in severe cases)

TREATMENT

A. Acute Viral Rhinosinusitis (AVRS) - Symptomatic Only

"All patients with acute sinusitis should be counselled about symptom-based treatments." - Harrison's 22E

No antibiotics for viral sinusitis. Symptomatic treatment:

Treatment	Drug/Dose	Notes
Analgesics/Antipyretics	Paracetamol or Ibuprofen	First-line for pain, fever
Nasal saline sprays/washes	High-volume isotonic saline	Clears mucus, reduces edema, promotes drainage
Oral decongestants	Pseudoephedrine 120 mg 12-hourly	Shrinks ostial mucosa → promotes drainage
Topical decongestants	Oxymetazoline (2 sprays BD)	Maximum 3-5 days only (risk of rhinitis medicamentosa)
Intranasal corticosteroids	Mometasone, Fluticasone	Helpful in allergic component or chronic rhinitis history
Mucolytics	Guaifenesin	Thins secretions
Facial hot packs	Warm compress over cheek	Symptomatic relief

Antihistamines should be AVOIDED in acute sinusitis - their drying effect thickens secretions and impairs drainage.

B. Antibiotic Therapy - When to Prescribe

Only ≤2% of sinusitis is bacterial; however, >70% of patients receive antibiotics - this is inappropriate. (Harrison's)

Criteria for antibiotic prescribing (Harrison's Table):

Indication	Definition
Persistent	Symptoms lasting ≥10 days without improvement
Severe	Fever >102°F (38.9°C) + purulent nasal discharge or facial pain for ≥3-4 consecutive days
Worsening ("double sickening")	New fever/headache/increased discharge after initial improvement of a viral URI lasting 5-6 days

Additional indications for antibiotics (Berek & Novak's):

Comorbidities: diabetes mellitus, chronic respiratory disease, congestive heart failure, immunodeficiency
High fever with systemic toxicity
Possible orbital or intracranial involvement
Unilateral acute maxillary tooth pain with purulent discharge

C. Antibiotic Regimens

First-Line:

Drug	Dose	Duration
Amoxicillin/Clavulanate (preferred)	875/125 mg BD	5-7 days (adults)
Amoxicillin (alternative)	875 mg PO BD or 1000 mg TDS	5-10 days

"Amoxicillin remains the treatment of choice. It is inexpensive, penetrates sinus tissues well, and can be changed if symptoms have not improved in 48-72 hours." - Berek & Novak's

If no improvement in 48-72 hours → switch to broader spectrum

Second-Line (or if beta-lactam resistant suspected):

Drug	Dose	Notes
Amoxicillin/Clavulanate high-dose	2000/125 mg BD × 7 days	For resistant organisms
Levofloxacin	500 mg OD × 5-10 days	Fluoroquinolone (risk: dysglycemia, neuropathy, tendon/aortic rupture)
Moxifloxacin	400 mg OD	Fluoroquinolone

Penicillin Allergy:

Allergy Type	Drug
Mild allergy	Cefuroxime (2nd gen cephalosporin)
Severe allergy	Doxycycline 200 mg OD × 5-10 days
Children, mild allergy	Cefdinir, cefuroxime, cefpodoxime (3rd gen cephalosporins)

Macrolides (azithromycin, clarithromycin) are specifically NOT recommended for sinusitis due to high rates of macrolide-resistant S. pneumoniae. Trimethoprim/sulphamethoxazole also not recommended due to resistance. (Harrison's)

Children (American Academy of Pediatrics guidelines):

Observation for 72 hours is acceptable for non-severe cases
Antibiotics indicated for: severe onset, worsening symptoms, or failure to improve in 72 hours
First-line: Amoxicillin ± clavulanate for minimum 10 days

D. Chronic Maxillary Sinusitis Treatment

Nasal saline irrigation (high-volume) - first-line
Intranasal corticosteroids - mainstay (mometasone, fluticasone, budesonide)
Macrolides (long-term, low-dose) - 12 weeks (clarithromycin/erythromycin) for CRSsNP (anti-inflammatory + antibacterial effect)
Oral corticosteroids - short course for acute exacerbations especially with polyps
Allergy management - antihistamines, leukotriene antagonists (montelukast) for allergic component
FESS (Functional Endoscopic Sinus Surgery) - for medically recalcitrant cases

E. Odontogenic Maxillary Sinusitis

Treat the causative dental pathology first - extraction/root canal of offending tooth, closure of oroantral fistula
Antibiotics - covering oral anaerobes (amoxicillin-clavulanate, metronidazole + amoxicillin, or clindamycin)
FESS/antrostomy - to drain and wash out the maxillary sinus of infected material
Most cases resolve after dental treatment + sinus washout

F. Fungal Maxillary Sinusitis

Type	Treatment
Mycetoma (non-invasive)	FESS removal of fungal ball; NO antifungals
AFRS	FESS + perioperative steroids; topical/oral steroids long-term; NO routine antifungals
Invasive fungal	IV antifungals (Amphotericin B for Mucor; Voriconazole for Aspergillus) + urgent surgical debridement; treat underlying immunosuppression

G. Nosocomial / ICU Sinusitis

Remove precipitating factor (nasotracheal tube, NG tube)
Broad-spectrum IV antibiotics (gram-negative coverage) until culture results available
Consider antral washout/drainage

H. Surgical Management - Antral Washout (Proof and Drain)

Indications for surgical drainage of maxillary sinus:

Failure of medical therapy
Intractable pain
Suspected complications
Fungal sinusitis
Odontogenic sinusitis with abscess
Immunocompromised patient

Procedures:

Antral washout (Proof puncture) - trocar inserted through inferior meatus to puncture medial wall; sinus irrigated with saline
FESS with middle meatal antrostomy - endoscopic widening of the natural ostium; procedure of choice
Caldwell-Luc operation - external approach via sublabial incision (largely obsolete, reserved for specific indications)
Intranasal antrostomy via inferior meatus - creates dependent drainage (less preferred now)

Complications of Untreated Maxillary Sinusitis

Complication	Notes
Orbital cellulitis / abscess	Via ethmoid extension; most common complication
Subperiosteal abscess	Facial bones
Cavernous sinus thrombosis	Via retrograde venous spread (danger triangle)
Meningitis	Via skull base
Brain abscess / Epidural abscess	Rare but serious
Osteomyelitis	Of facial bones
Mucocele / Mucopyocele	Chronic obstruction leading to cystic distension

Summary Table - Treatment at a Glance

Scenario	Treatment
Viral sinusitis	Saline, decongestants (≤3-5 days topical), analgesics, INCS
ABRS (mild, no criteria)	Watchful waiting + symptomatic
ABRS (criteria met)	Amoxicillin/clavulanate 875/125 mg BD × 5-7 days
Penicillin allergy (mild)	Cefuroxime
Penicillin allergy (severe)	Doxycycline
NOT recommended	Macrolides, TMP-SMX (resistance)
Antihistamines in acute	AVOID (drying effect worsens drainage)
Chronic (medical)	INCS + saline irrigation ± macrolides
Odontogenic	Dental treatment + amoxicillin-clavulanate + FESS
Fungal (mycetoma)	FESS removal only
Invasive fungal	IV amphotericin B + urgent surgery
Complicated/refractory	FESS / antral washout

EXPLANATION (Simple Language)

Why Does Maxillary Sinusitis Happen?

Imagine your maxillary sinus like a small room with a tiny window (the ostium/drainage hole) located near the ceiling of the room, not the floor. This is a design flaw: gravity cannot drain it naturally. When you get a cold or allergy, the lining swells up and blocks this tiny window completely. Now the room fills up with stagnant mucus that cannot drain.

In this warm, dark, airless environment - bacteria love to grow. The three most common bacteria (like "unwanted guests") are Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis - the same organisms that cause ear and chest infections in children.

There is also a unique cause specific to the maxillary sinus: dental infections. The roots of your upper molar and premolar teeth poke up so close to the sinus floor that a tooth abscess can directly infect the sinus from below - like neighbours whose fire spreads through a shared wall.

Why Is Treatment Mostly Symptomatic?

More than 90% of sinusitis is viral. Antibiotics cannot kill viruses. The body clears the virus in 7-10 days on its own. So most patients only need:

Pain relief (paracetamol/ibuprofen) for the cheek and tooth pain
Saline washes to clear out the blocked passages
Decongestant sprays (for maximum 3-5 days only) to shrink the swollen window/ostium and let the sinus drain

If you use decongestant nasal sprays for more than 3-5 days, the blood vessels become dependent on the drug to stay constricted, and when you stop, they rebound and swell even more - this is called "rhinitis medicamentosa."

Antihistamines should be avoided in acute sinusitis despite being popular - they dry up secretions and make the sticky mucus even thicker, making it harder to drain.

When Do Antibiotics Help?

Only when symptoms last more than 10 days without improvement, or the patient has high fever + purulent discharge for 3-4 straight days, or there is a pattern of "double sickening" (initial improvement followed by sudden worsening). In such cases, the bacterial takeover has occurred and antibiotics are warranted. Amoxicillin-clavulanate is the antibiotic of choice because it covers the major organisms and is also effective against beta-lactamase-producing strains.

The Danger of Untreated Sinusitis

The maxillary sinus sits just below the orbit (eye socket). If infection spreads, it can cause orbital cellulitis and abscess (the most common complication). The facial veins drain backward through the cavernous sinus in the brain - making cavernous sinus thrombosis a feared but rare complication. Any patient with eye swelling, double vision, or change in consciousness after sinusitis must be treated as an emergency.

Sources

K.J. Lee's Essential Otolaryngology - Rhinosinusitis (Pathogenesis, Bacteriology, Treatment)
Harrison's Principles of Internal Medicine 22E (2025) - Acute and Chronic Sinusitis
Berek & Novak's Gynecology - Sinusitis section
Scott-Brown's Otorhinolaryngology Head & Neck Surgery Vol.1 & 2
Vitali FC et al. Global Prevalence of Maxillary Sinusitis of Odontogenic Origin. J Endod. 2023 (PMID: 36754253)
Allevi F et al. Treatment of Sinusitis Following Dental Implantation: Meta-Analysis. Am J Rhinol Allergy. 2022 (PMID: 35244478)

This is a shared conversation. Sign in to Orris to start your own chat.